Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.10.0.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2018
Dec. 31, 2017
Current assets:    
Cash and cash equivalents $ 80,381 $ 91,499
Accounts receivable, net 152,777 165,516
Inventory, net 46,753 49,333
Other current assets and prepaid expenses 41,651 42,513
Total current assets 321,562 348,861
Property, plant and equipment, net 150,156 146,557
Intangible assets, net 648,541 683,835
In-process research and development 645,714 647,347
Goodwill 714,234 717,099
Investments 45,497 40,642
Other assets 5,246 5,615
Total assets 2,530,950 2,589,956
Current liabilities:    
Accounts payable 69,061 74,307
Accrued expenses 200,992 230,301
Current portion of 2033 Senior Notes 30,343 0
Current portion of lines of credit and notes payable 6,465 11,926
Total current liabilities 306,861 316,534
2023 Convertible Notes and 2033 Senior Notes 55,894 29,160
Deferred tax liabilities, net 148,255 148,729
Other long-term liabilities, principally contract liabilities, contingent consideration and line of credit 209,444 239,955
Total long-term liabilities 413,593 417,844
Total liabilities 720,454 734,378
Equity:    
Common Stock - $0.01 par value, 750,000,000 shares authorized; 560,169,422 and 560,023,745 shares issued at June 30, 2018 and December 31, 2017, respectively 5,602 5,600
Treasury Stock - 549,907 and 549,907 shares at June 30, 2018 and December 31, 2017, respectively (1,791) (1,791)
Additional paid-in capital 2,901,086 2,889,256
Accumulated other comprehensive loss (13,004) (528)
Accumulated deficit (1,081,397) (1,036,959)
Total shareholders’ equity 1,810,496 1,855,578
Total liabilities and equity $ 2,530,950 $ 2,589,956